LABDvsREW
DIREXION DAILY S&P BIOTECH BEAR 3X SHARES against ProShares UltraShort Technology — the fee, the flows, the book, and a year head-to-head.
Head to head
| LABD | REW | |
|---|---|---|
| Expense ratio | — | 0.95% |
| Assets | $138M | $3875.11T |
| Net flow, 1 month | +$55M | +$930 |
| Net flow, 1 year | +$183M | +$4K |
| Return, YTD | -64.4% | -55.0% |
| Return, 1 year | -80.1% | -56.7% |
| Avg daily volume | 21.9M | 49K |
| Holdings | 1 | 9 |
| Listed | Jul 31, 2024 | Feb 2, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS